Skip to main content
. 2015 Nov 24;19:149–157. doi: 10.1007/s11102-015-0693-y

Fig. 3.

Fig. 3

Changes in AcroQoL scores for patients with and without biochemical control during treatment with Lanreotide Autogel. AcroQoL acromegaly quality of life questionnaire, CI confidence interval. Asterisks indicate non-overlapping CIs, i.e. statistically significant between-group differences. Baseline scores are summarized in Table 1